These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21528804)

  • 1. Sex steroid priming for growth hormone (GH) provocative tests: an endless debate with insufficient solutions.
    Zadik Z
    J Pediatr Endocrinol Metab; 2011; 24(1-2):3-4. PubMed ID: 21528804
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex hormone priming.
    Lanes R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):7-8. PubMed ID: 21528806
    [No Abstract]   [Full Text] [Related]  

  • 3. Pros of priming in the diagnosis of growth hormone deficiency.
    Gonc EN; Ozon A; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2011; 24(1-2):9-11. PubMed ID: 21528807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not ready for prime time.
    Gumus P; Chalew S
    J Pediatr Endocrinol Metab; 2011; 24(1-2):5-6. PubMed ID: 21528805
    [No Abstract]   [Full Text] [Related]  

  • 5. The pros and cons of sex steroid priming in growth hormone stimulation testing.
    Wetterau LA
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1049-55. PubMed ID: 23329747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is priming with sex steroids useful for defining patients who will benefit from GH treatment?
    De Sanctis V; Soliman AT; Yassin M; Di Maio S
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):284-7. PubMed ID: 24716393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid priming in short stature children unresponsive to GH stimulation tests: Why, who, when and how.
    Partenope C; Galazzi E; Albanese A; Bellone S; Rabbone I; Persani L
    Front Endocrinol (Lausanne); 2022; 13():1072271. PubMed ID: 36523598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions.
    Naderi F; Eslami SR; Mirak SA; Khak M; Amiri J; Beyrami B; Shekarchi B; Poureisa M
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):117-23. PubMed ID: 25153566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in sex steroid priming for growth hormone stimulation testing in UK.
    Frerichs C; Raymond L; Senniappan S
    Arch Dis Child; 2017 Mar; 102(3):294. PubMed ID: 27789462
    [No Abstract]   [Full Text] [Related]  

  • 10. Testing for growth hormone deficiency in children.
    Richmond E; Rogol AD
    Growth Horm IGF Res; 2020 Feb; 50():57-60. PubMed ID: 31865218
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex hormone priming for growth hormone stimulation testing in pre- and early adolescent children is evidence based.
    Rosenbloom AL
    Horm Res Paediatr; 2011; 75(1):78-80. PubMed ID: 21252560
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
    Scaroni C; Ceccato F; Rizzati S; Mantero F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boy with "transient" growth hormone deficiency in prepubertal stage despite normal growth hormone secretion in childhood and after puberty.
    Kashimada K; Onishi T; Ono M; Miyai K; Ohta M; Mizutani S
    Endocr J; 2007 Dec; 54(6):1015-9. PubMed ID: 18000342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
    Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
    Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performing L-proline oral test (500 mg/kg) in growth disturbances: cases of excessive inhibition of GH release and cases of defective proline-mediated GH release.
    Popa M; Simionescu L
    Endocrinologie; 1982; 20(3):193-7. PubMed ID: 6128783
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition to the adult endocrine clinic: testing pituitary function - what tests and when?
    Geffner ME
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S117-21. PubMed ID: 12914739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New guidelines for the diagnosis of growth hormone deficiency in adults.
    Casanueva FF; Castro AI; Micic D; Kelestimur F; Dieguez C
    Horm Res; 2009 Jan; 71 Suppl 1():112-5. PubMed ID: 19153519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constitutional delay of growth and puberty].
    Cavallo L; Acquafredda A; Zecchino C; Delvecchio M
    Minerva Pediatr; 2001 Oct; 53(5):423-5. PubMed ID: 11668263
    [No Abstract]   [Full Text] [Related]  

  • 20. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity.
    Di Somma C; Savastano S; Rota F; Savanelli MC; Pagano L; Pizza G; Lombardi G; Aimaretti G; Colao A
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):21-6. PubMed ID: 19020381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.